Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.25)
# 999
Out of 5,054 analysts
106
Total ratings
44.71%
Success rate
3.47%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Buy | $16 → $19 | $16.59 | +14.53% | 9 | Nov 7, 2025 | |
| NTRA Natera | Maintains: Buy | $200 → $250 | $206.72 | +20.94% | 10 | Nov 7, 2025 | |
| VCYT Veracyte | Maintains: Hold | $40 → $43 | $42.66 | +0.80% | 2 | Nov 5, 2025 | |
| TEM Tempus AI | Maintains: Buy | $110 → $95 | $71.56 | +32.76% | 2 | Nov 5, 2025 | |
| ILMN Illumina | Maintains: Hold | $105 → $112 | $122.60 | -8.65% | 13 | Oct 31, 2025 | |
| GH Guardant Health | Maintains: Buy | $75 → $100 | $97.71 | +2.34% | 9 | Oct 30, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $155 → $160 | $139.91 | +14.36% | 2 | Oct 29, 2025 | |
| RGEN Repligen | Maintains: Hold | $150 → $165 | $153.44 | +7.53% | 4 | Oct 29, 2025 | |
| XGN Exagen | Maintains: Buy | $11 → $15 | $9.22 | +62.69% | 5 | Oct 27, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1 → $2 | $1.58 | +26.58% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $85 | $83.39 | +1.93% | 4 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $8.34 | +139.81% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 | $34.97 | +5.80% | 5 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $5 | $5.00 | - | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.86 | +61.29% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.04 | +188.46% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $67.50 | +11.11% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.38 | +426.32% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.35 | +13,957.14% | 1 | Mar 30, 2021 |
10x Genomics
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $16.59
Upside: +14.53%
Natera
Nov 7, 2025
Maintains: Buy
Price Target: $200 → $250
Current: $206.72
Upside: +20.94%
Veracyte
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $42.66
Upside: +0.80%
Tempus AI
Nov 5, 2025
Maintains: Buy
Price Target: $110 → $95
Current: $71.56
Upside: +32.76%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $105 → $112
Current: $122.60
Upside: -8.65%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $75 → $100
Current: $97.71
Upside: +2.34%
GeneDx Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $155 → $160
Current: $139.91
Upside: +14.36%
Repligen
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $153.44
Upside: +7.53%
Exagen
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $9.22
Upside: +62.69%
Quantum-Si incorporated
Oct 27, 2025
Maintains: Hold
Price Target: $1 → $2
Current: $1.58
Upside: +26.58%
Oct 22, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $83.39
Upside: +1.93%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $8.34
Upside: +139.81%
Sep 9, 2025
Maintains: Buy
Price Target: $37
Current: $34.97
Upside: +5.80%
Aug 11, 2025
Downgrades: Hold
Price Target: $12 → $5
Current: $5.00
Upside: -
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.86
Upside: +61.29%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.04
Upside: +188.46%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $67.50
Upside: +11.11%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.38
Upside: +426.32%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.35
Upside: +13,957.14%